RXRX Sep 2024 9.000 call
| Previous close | 1.8000 |
| Open | 1.8000 |
| Bid | 1.7500 |
| Ask | 1.9500 |
| Strike | 9.00 |
| Expiry date | 2024-09-20 |
| Day's range | 1.7300 - 1.8500 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.14k |
Barrons.comNvidia Owns These 4 Stocks. Here’s How They’re Doing.
Nvidia has been one of the best-performing stocks on Wall Street since 2023, amassing holdings in four companies along the way.
GlobeNewswireRecursion to Participate in Upcoming Investor Conferences
SALT LAKE CITY, June 03, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conferences: Jefferies Healthcare Conference - June 5-6, 2024 45th Annual Goldman Sachs Healthcare Conference - June 10-13, 2024 Morgan Stanley 3rd Annual Life Sciences AI Summit - June 26-27, 2024 About Recursion Recursion is a clinical stage TechBio company leading the s
GuruFocus.comInsider Sale: Director Blake Borgeson Sells Shares of Recursion Pharmaceuticals Inc (RXRX)
On May 28, 2024, Blake Borgeson, Director at Recursion Pharmaceuticals Inc (NASDAQ:RXRX), executed a sale of 11,447 shares of the company.
